Prevention of NF-kappaB activation in vivo by a cell-permeable NF-kappaB inhibitor peptide (Q42813660)

7 November 2017

Prevention of NF-kappaB activation in vivo by a cell-permeable NF-kappaB inhibitor peptide (English)

1 reference

7 November 2017

0 references

1

Ana L Mora

1 reference

7 November 2017

John LaVoy

2

1 reference

7 November 2017

Martha McKean

3

1 reference

7 November 2017

Arlene Stecenko

4

1 reference

7 November 2017

Kenneth L Brigham

5

1 reference

7 November 2017

Richard Parker

6

1 reference

7 November 2017

Mauricio Rojas

7

1 reference

7 November 2017

10 June 2005

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

7 November 2017

1 reference

7 November 2017

289

1 reference

7 November 2017

4

1 reference

7 November 2017

L536-44

1 reference

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Series introduction: the transcription factor NF-kappaB and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

CD40 regulates the processing of NF-kappaB2 p100 to p52

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Removal of endotoxin from recombinant protein preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Oscillations in NF-kappaB signaling control the dynamics of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Genetic engineering of proteins with cell membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

Chemical engineering of cell penetrating antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00164.2005

10.1152/AJPLUNG.00164.2005

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference